These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1343896)

  • 1. Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations.
    King CH; Muchiri EM; Ouma JH
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():203-10. PubMed ID: 1343896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection.
    King CH; Lombardi G; Lombardi C; Greenblatt R; Hodder S; Kinyanjui H; Ouma J; Odiambo O; Bryan PJ; Muruka J
    Am J Trop Med Hyg; 1988 Sep; 39(3):295-305. PubMed ID: 3140683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-based control of schistosomiasis haematobia. II. Metrifonate vs. praziquantel in control of infection-associated morbidity.
    King CH; Lombardi G; Lombardi C; Greenblatt R; Hodder S; Kinyanjui H; Ouma J; Odiambo O; Bryan PJ; Muruka J
    Am J Trop Med Hyg; 1990 Jun; 42(6):587-95. PubMed ID: 2115308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-based control of schistosomiasis haematobia. IV. Impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya.
    King CH; Muchiri E; Ouma JH; Koech D
    Am J Trop Med Hyg; 1991 Oct; 45(4):498-508. PubMed ID: 1951859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya.
    King CH; Keating CE; Muruka JF; Ouma JH; Houser H; Siongok TK; Mahmoud AA
    Am J Trop Med Hyg; 1988 Oct; 39(4):361-8. PubMed ID: 3142286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates.
    El-Khoby T; Galal N; Fenwick A; Barakat R; El-Hawey A; Nooman Z; Habib M; Abdel-Wahab F; Gabr NS; Hammam HM; Hussein MH; Mikhail NN; Cline BL; Strickland GT
    Am J Trop Med Hyg; 2000 Feb; 62(2 Suppl):88-99. PubMed ID: 10813505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of low-dose versus standard-dose praziquantel therapy in treatment of urinary tract morbidity due to Schistosoma haema tobium infection.
    King CH; Muchiri EM; Mungai P; Ouma JH; Kadzo H; Magak P; Koech DK
    Am J Trop Med Hyg; 2002 Jun; 66(6):725-30. PubMed ID: 12224581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity induced by Schistosoma haematobium infections, as assessed by ultrasound before and after treatment with praziquantel, in a recently expanded focus (Senegal River basin).
    Delegue P; Picquet M; Shaw DJ; Vercruysse J; Sambou B; Ly A
    Ann Trop Med Parasitol; 1998 Oct; 92(7):775-83. PubMed ID: 9924535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-finding study for praziquantel therapy of Schistosoma haematobium in Coast Province, Kenya.
    King CH; Wiper DW; De Stigter KV; Peters PA; Koech D; Ouma JH; Arap Siongok TK; Mahmoud AA
    Am J Trop Med Hyg; 1989 May; 40(5):507-13. PubMed ID: 2499203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term suppression of adult bladder morbidity and severe hydronephrosis following selective population chemotherapy for Schistosoma haematobium.
    Subramanian AK; Mungai P; Ouma JH; Magak P; King CH; Mahmoud AA; King CL
    Am J Trop Med Hyg; 1999 Sep; 61(3):476-81. PubMed ID: 10497994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial.
    Barda B; Coulibaly JT; Hatz C; Keiser J
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005400. PubMed ID: 28222149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of metrifonate in a highly endemic area of urinary schistosomiasis in Kenya.
    Sato K; Shimada M; Noda S; Muhoho ND; Katsumata T; Sato A; Aoki Y
    Am J Trop Med Hyg; 1988 Jan; 38(1):81-5. PubMed ID: 3124647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound Evolution of Pediatric Urinary Schistosomiasis after Treatment with Praziquantel in a Highly Endemic Area.
    Bocanegra C; Pintar Z; Mendioroz J; Serres X; Gallego S; Nindia A; Aznar ML; Soriano-Arandes A; Salvador F; Gil E; Sikaleta N; Moreno M; Molina I
    Am J Trop Med Hyg; 2018 Oct; 99(4):1011-1017. PubMed ID: 30141396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
    Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
    Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of schistosomiasis in Egypt: Minya Governorate.
    Gabr NS; Hammad TA; Orieby A; Shawky E; Khattab MA; Strickland GT
    Am J Trop Med Hyg; 2000 Feb; 62(2 Suppl):65-72. PubMed ID: 10813502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonographic assessment of urinary tract lesions due to Schistosoma haematobium in Niger after four consecutive years of treatment with praziquantel.
    Laurent C; Lamothe F; Develoux M; Sellin B; Mouchet F
    Trop Med Parasitol; 1990 Jun; 41(2):139-42. PubMed ID: 2116659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine circulating soluble egg antigen in relation to egg counts, hematuria, and urinary tract pathology before and after treatment in children infected with Schistosoma haematobium in Kenya.
    Kahama AI; Odek AE; Kihara RW; Vennervald BJ; Kombe Y; Nkulila T; Hatz CF; Ouma JH; Deelder AM
    Am J Trop Med Hyg; 1999 Aug; 61(2):215-9. PubMed ID: 10463669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of praziquantel on hematuria and proteinuria in urinary schistosomiasis.
    Mott KE; Dixon H; Osei-Tutu E; England EC; Davis A
    Am J Trop Med Hyg; 1985 Nov; 34(6):1119-26. PubMed ID: 3938926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection.
    Hodder SL; Mahmoud AA; Sorenson K; Weinert DM; Stein RL; Ouma JH; Koech D; King CH
    Am J Trop Med Hyg; 2000; 63(3-4):133-8. PubMed ID: 11388504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
    Chisango TJ; Ndlovu B; Vengesai A; Nhidza AF; Sibanda EP; Zhou D; Mutapi F; Mduluza T
    BMC Infect Dis; 2019 Mar; 19(1):219. PubMed ID: 30832614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.